BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 2761380)

  • 1. Quantitative and qualitative fat analysis in human leg muscle of neuromuscular diseases by 1H MR spectroscopy in vivo.
    Bárány M; Venkatasubramanian PN; Mok E; Siegel IM; Abraham E; Wycliffe ND; Mafee MF
    Magn Reson Med; 1989 May; 10(2):210-26. PubMed ID: 2761380
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human leg neuromuscular diseases: P-31 MR spectroscopy.
    Bárány M; Siegel IM; Venkatasubramanian PN; Mok E; Wilbur AC
    Radiology; 1989 Aug; 172(2):503-8. PubMed ID: 2748832
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vivo H-1 spectroscopy in humans at 1.5 T.
    Bárány M; Langer BG; Glick RP; Venkatasubramanian PN; Wilbur AC; Spigos DG
    Radiology; 1988 Jun; 167(3):839-44. PubMed ID: 3283842
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Observation of intramyocellular lipids by 1H-magnetic resonance spectroscopy.
    Boesch C; Kreis R
    Ann N Y Acad Sci; 2000 May; 904():25-31. PubMed ID: 10865706
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diagnostic value of proton MR spectroscopy in peripheral arterial occlusive disease: a prospective evaluation.
    Stueckle CA; Claeys L; Haegele K; Zimmermann S; Mruck S; Adams S; Liermann D
    AJR Am J Roentgenol; 2006 Nov; 187(5):1322-6. PubMed ID: 17056923
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 1H magnetic resonance spectroscopy of invasive cervical cancer: an in vivo study with ex vivo corroboration.
    Mahon MM; Williams AD; Soutter WP; Cox IJ; McIndoe GA; Coutts GA; Dina R; deSouza NM
    NMR Biomed; 2004 Feb; 17(1):1-9. PubMed ID: 15011245
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Calf enlargement in neuromuscular diseases: a quantitative ultrasound study in 350 patients and review of the literature.
    Reimers CD; Schlotter B; Eicke BM; Witt TN
    J Neurol Sci; 1996 Nov; 143(1-2):46-56. PubMed ID: 8981297
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ex vivo proton MR spectroscopy (1H-MRS) for evaluation of human gastric carcinoma.
    Mun CW; Cho JY; Shin WJ; Choi KS; Eun CK; Cha SS; Lee J; Yang YI; Nam SH; Kim J; Lee SY
    Magn Reson Imaging; 2004 Jul; 22(6):861-70. PubMed ID: 15234456
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adipose tissue abnormalities in cystic fibrosis: noninvasive determination of mono- and polyunsaturated fatty acids by carbon-13 topical magnetic resonance spectroscopy.
    Dimand RJ; Moonen CT; Chu SC; Bradbury EM; Kurland G; Cox KL
    Pediatr Res; 1988 Aug; 24(2):243-6. PubMed ID: 3186335
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular dynamics and information on possible sites of interaction of intramyocellular metabolites in vivo from resolved dipolar couplings in localized 1H NMR spectra.
    Schröder L; Schmitz C; Bachert P
    J Magn Reson; 2004 Dec; 171(2):213-24. PubMed ID: 15546747
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Volume-selective water-suppressed proton spectra of human brain and muscle in vivo.
    Bárány M; Venkatasubramanian PN
    NMR Biomed; 1989 Jun; 2(1):7-11. PubMed ID: 2641292
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vivo H1 MR spectroscopy using 3 Tesla to investigate the metabolic profiles of joint fluids in different types of knee diseases.
    Jin W; Woo DC; Jahng GH
    J Appl Clin Med Phys; 2016 Mar; 17(2):561-572. PubMed ID: 27074491
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vivo 1H spectroscopic studies of human gastrocnemius muscle at 1.5 T.
    Narayana PA; Hazle JD; Jackson EF; Fotedar LK; Kulkarni MV
    Magn Reson Imaging; 1988; 6(5):481-5. PubMed ID: 3226233
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Muscle MRS detects elevated PDE/ATP ratios prior to fatty infiltration in Becker muscular dystrophy.
    Wokke BH; Hooijmans MT; van den Bergen JC; Webb AG; Verschuuren JJ; Kan HE
    NMR Biomed; 2014 Nov; 27(11):1371-7. PubMed ID: 25196814
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Muscle carnitine levels in neuromuscular disease.
    Borum PR; Broquist HP; Roelops RJ
    J Neurol Sci; 1977 Nov; 34(2):279-86. PubMed ID: 925714
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Muscle metabolism in Duchenne muscular dystrophy assessed by in vivo proton magnetic resonance spectroscopy.
    Hsieh TJ; Jaw TS; Chuang HY; Jong YJ; Liu GC; Li CW
    J Comput Assist Tomogr; 2009; 33(1):150-4. PubMed ID: 19188804
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MRI of normal and pathologic skeletal muscle.
    Murphy WA; Totty WG; Carroll JE
    AJR Am J Roentgenol; 1986 Mar; 146(3):565-74. PubMed ID: 3484872
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Natural abundance 13C NMR spectra of human muscle, normal and diseased.
    Bárány M; Doyle DD; Graff G; Westler WM; Markley JL
    Magn Reson Med; 1984 Mar; 1(1):30-43. PubMed ID: 6571435
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rehabilitation interventions for foot drop in neuromuscular disease.
    Sackley C; Disler PB; Turner-Stokes L; Wade DT; Brittle N; Hoppitt T
    Cochrane Database Syst Rev; 2009 Jul; (3):CD003908. PubMed ID: 19588347
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An autoradiographic study of muscular dystrophy, motor neuron disease and Charcot-Marie-Tooth disease.
    Monckton G; Marusyk H
    Can J Neurol Sci; 1977 Feb; 4(1):25-9. PubMed ID: 837261
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.